As artificial intelligence reshapes global industry, a Davos-recognized entrepreneur is advancing a provocative thesis: that ethics cannot be added to AI after the fact - it must be built in from the ...

Orforglipron's launch and Medicare/Medicaid eligibility will expand Eli Lilly's addressable market and offset price erosion.